Brainstorm Cell Therapeutics In

Q3 2022 13F Holders

Symbol
BCLI
CUSIP
10501E201
Type
Equity
Class
COM NEW
Num filings
49
Total reported value, excl. options
$17.1 M
Manager Report Date Value ($000) Shares Option Type